Health News
FDA Drug Safety Communication: Diflucan
The U.S. Food and Drug Administration (FDA) is informing the public that chronic, high doses (400-800 mg/day) of the antifungal drug Diflucan ( fluconazole ) may be associated with a rare and distinct set of birth defects in infants whose mothers were treated with the drug during the first trimester of pregnancy.
FDA: Unapproved Emergency Birth Control May Be Ineffective, Unsafe
The U.S. Food and Drug Administration (FDA) is warning U.S. consumers not to use the emergency birth control medicine labeled as Evital . These products may be counterfeit versions of the “morning after pill” and may not be safe or effective in preventing pregnancy.
Evital has not been approved by the FDA for use in the United States.
This potentially ineffective and suspect counterfeit emergency birth control may also be in distribution in some Hispanic communities in the United States.
The packaging label of the potentially ineffective and suspect counterfeit version says, ...
Florida Firm Recalls Imported Beef Products Due To Potential Animal Drug Contaminant
Northwestern Meat, Inc., a Miami, Fla. firm, is recalling approximately 6,240 pounds of frozen boneless beef products imported from Honduras that may contain the animal drug Ivermectin , the U.S. Department of Agriculture’s Food Safety and Inspection Service ( FSIS ) announced today.
Tri State Beef Recall Due To E. Coli Risk
Tri State Beef, a Cincinnati, Ohio, establishment, is recalling approximately 228,596 pounds of beef products that may be contaminated with E. coli O157 : H7 , the U.S. Department of Agriculture’s Food Safety and Inspection Service ( FSIS ) announced today.
The following product is subject to recall:
Combo bins of "TRI-STATE BEEF CO., INC BONELESS BEEF."
Each bin bears the establishment number "EST. 1750" inside the USDA mark of inspection. The products subject to recall were produced between July 19, 2011 and July 22, 2011, and sold to federally-inspected establishments for ...
FDA Drug Safety Communication: Methylene blue (UPDATE)
The U.S. Food and Drug Administration (FDA) has received reports of serious central nervous system (CNS) reactions when the drug methylene blue is given to patients taking psychiatric medications that work through the serotonin system of the brain ( serotonergic psychiatric medications).
Foodborne Outbreak Potentially Associated With Papaya
The FDA is warning consumers not to eat papayas from Agromod Produce, Inc., a distributor in McAllen,Texas.
FDA Drug Safety Communication: Pradaxa
The U.S. Food and Drug Administration (FDA) is alerting the public to important storage and handling requirements for Pradaxa ( dabigatran etexilate mesylate ) capsules.
(UPDATE 12/19) FDA Drug Safety Communication: Multaq (dronedarone)
The U.S. Food and Drug Administration (FDA) is reviewing data from a clinical trial that was evaluating the effects of the antiarrhythmic drug Multaq ( dronedarone ) in patients with permanent atrial fibrillation.
Safeguarding Against Swimmer's Ear
Maybe it starts with a grumpy child holding their ear. Perhaps your first thought is an ear infection. But with broiling summer days coaxing families to beaches and pools, it may be something else.
Reducing Risks Could Cut Alzheimer's
Moderate lifestyle changes may seem small, but they can provide large returns in better health. Exercising and smoking cessation are among modifiable changes capable of reducing risk of Alzheimer's disease.